 ATLANTA and SAN DIEGO, Nov. 13, 2022 GLOBE NEWSWIRE -- Sofusa, a wholly-owned division of Sorrento Therapeutics Nasdaq: SRNE, Sorrento, today announced that it will host a virtual Key Opinion Leader KOL panel discussion titled Empowering the Lymphatics: Unleashing the Potential of Biologics that Target the Immune System to be held on Thursday, November 17, 2022 at 11:30 AM EST. 